Pomerantz Law Firm Investigates Claims on Behalf of Investors of Synovis Life Technologies, Inc.
13 Dezembro 2011 - 5:35PM
Business Wire
Pomerantz Haudek Grossman & Gross LLP is investigating
claims on behalf of investors of Synovis Life Technologies, Inc.
(“Synovis” or the “Company”) (NASDAQ:SYNO) concerning the proposed
acquisition of Synovis by Baxter International Inc. in a
transaction valued at approximately $325 million or $260 million
after adjusting for the net cash.
The investigation concerns whether the Synovis directors are
breaching their fiduciary duties by failing to adequately shop the
Company and maximize shareholder value. Under the terms of the
agreement, the Price to EBITDA multiple that Baxter would be paying
is below that of comparable transactions.
Synovis shareholders seeking more information about this
acquisition are advised to contact Gustavo Bruckner, Esq. at
gfbruckner@pomlaw.com or 212-661-1100 or toll free at 888-476-6529,
ext. 302. Shareholders may also contact Rachelle R. Boyle at
rrboyle@pomlaw.com or 212-661-1100 or 888-476-6529, ext. 237.
The Pomerantz Firm, with offices in New York, Chicago, and
Washington, D.C., is acknowledged as one of the premier firms in
the areas of corporate, securities, and antitrust class litigation.
Founded by the late Abraham L. Pomerantz, known as the dean of the
class action bar, the Pomerantz Firm pioneered the field of
securities class actions. Today, more than 70 years later, the
Pomerantz Firm continues in the tradition he established, fighting
for the rights of the victims of securities fraud, breaches of
fiduciary duty, and corporate misconduct. The Firm has recovered
numerous multimillion-dollar damages awards on behalf of class
members. See www.pomerantzlaw.com.
Synovis Life Technologies, Inc. (MM) (NASDAQ:SYNO)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Synovis Life Technologies, Inc. (MM) (NASDAQ:SYNO)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024
Notícias em tempo-real sobre Synovis Life Technologies, Inc. (MM) da NASDAQ bolsa de valores: 0 artigos recentes
Mais Notícias de Pomerantz Haudek Grossman & Gross LLP